-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicure net loss narrows 5% to CAD 1.32 million for quarter ended Sept. 30, 2026

PUBT·11/19/2026 21:01:19
Listen to the news
Medicure net loss narrows 5% to CAD 1.32 million for quarter ended Sept. 30, 2026
  • Medicure reported a 5% narrower net loss of CAD 1.32 million for the quarter ended September 30, 2026, versus a year earlier.
  • Quarterly net revenue fell year over year to CAD 7.91 million.
  • Cash and cash equivalents dropped 72% from December 31, 2025, to CAD 1.08 million at September 30, 2026.
  • Quarterly research and development spending declined 6% year over year to CAD 676,000; programs include the Phase 3 MC-1 trial for PNPO deficiency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicure Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611191600ACCESSWRNAPR_____1254353) on November 19, 2026, and is solely responsible for the information contained therein.